Description |
glycogen phosphorylase, muscle associated |
proteasome maturation protein |
Image |
|
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Pyridoxal phosphate
- Beta-D-Glucopyranose Spirohydantoin
- (5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione
- alpha-D-glucose 6-phosphate
- N-beta-D-glucopyranosylacetamide
- Monofluorophosphate ion
- Beta-D-Glucose
- 3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
- Nojirimycine Tetrazole
- Indirubin-5-sulphonate
- 2-Deoxy-Glucose-6-Phosphate
- C-(1-hydrogyl-beta-D-glucopyranosyl) formamide
- alpha-D-glucopyranosyl-2-carboxylic acid amide
- alpha-D-glucose-1-phosphate
- 8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one
- 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole
- N-acetyl-N'-beta-D-glucopyranosyl urea
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole
- C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole
- CP-320626
- (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester
- 8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
- Alvocidib
- 1-deoxy-1-methoxycarbamido-beta-D-glucopyranose
- N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide
- 1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide
- 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
- 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium
- N(6)-(pyridoxal phosphate)-L-lysine
- Heptulose-2-Phosphate
- N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine
- Dexfosfoserine
- 1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide
- Inosinic Acid
- 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID
- 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID
- 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID
- 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID
- 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL
- ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid
- (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol
- 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID
- (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
- (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
|
|
Diseases |
|
|
GWAS |
|
|
Interacting Genes |
31 interacting genes:
AGTPBP1
ARID1B
CDC42BPB
CLASP2
DNM2
ERO1B
FADS2
FAM110A
IGBP1
INTS4
LMNA
NIPSNAP2
NTAQ1
PDE4DIP
POMP
PPP1CA
PPP1R3B
PPP2CA
PRKAB2
PYGB
PYGL
S100A1
SGCG
SRP72
TOP1
TRAPPC2
TRIM54
TRIM55
TRIM63
TTN
WWP1
|
25 interacting genes:
ARMT1
ATXN1
CAPN3
ECT2
FAM107A
GPD1
GRB2
KCNA10
KIF1B
KLHL41
MPPED2
PSMA1
PSMA3
PSMB1
PSMB10
PSMB5
PSMB6
PSMB7
PSMB8
PSMB9
PYGM
RBM5
SSR4
TTN
VCL
|
Entrez ID |
5837 |
51371 |
HPRD ID |
01986 |
12613 |
Ensembl ID |
ENSG00000068976
|
ENSG00000132963
|
Uniprot IDs |
P11217
|
Q9Y244
|
PDB IDs |
1Z8D
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|